Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Agex Therapeutics Inc (AGE)

Agex Therapeutics Inc (AGE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,772
  • Shares Outstanding, K 37,943
  • Annual Sales, $ 140 K
  • Annual Income, $ -8,680 K
  • 60-Month Beta 1.39
  • Price/Sales 160.55
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AGE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.19
  • Most Recent Earnings -0.07 on 05/13/22
  • Next Earnings Date 08/12/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5738 unch
on 06/24/22
0.9000 -36.24%
on 05/26/22
-0.1562 (-21.40%)
since 05/24/22
3-Month
0.5738 unch
on 06/24/22
1.1200 -48.77%
on 04/26/22
-0.3067 (-34.83%)
since 03/24/22
52-Week
0.5162 +11.16%
on 12/20/21
1.7100 -66.44%
on 06/30/21
-0.9062 (-61.23%)
since 06/24/21

Most Recent Stories

More News
Dr. Joanne Hackett Appointed Chairperson of AgeX Board of Directors

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that Dr. Joanne Hackett has been appointed Chairperson...

AGE : 0.5738 (-5.83%)
AgeX Therapeutics Reports First Quarter 2022 Financial Results

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter...

AGE : 0.5738 (-5.83%)
AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter...

AGE : 0.5738 (-5.83%)
AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced today a research collaboration with the...

AGE : 0.5738 (-5.83%)
AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001

AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced today that ImStem Biotechnology, Inc. (“ImStem”),...

AGE : 0.5738 (-5.83%)
AgeX Therapeutics Receives Stock Exchange Deficiency Letter

AgeX Therapeutics , Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on November 17, 2021 it received a letter...

AGE : 0.5738 (-5.83%)
AgeX Therapeutics Reports Third Quarter 2021 Financial Results

AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter...

AGE : 0.5738 (-5.83%)
AgeX Therapeutics Reports Second Quarter 2021 Financial Results

AgeX Therapeutics , Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter...

AGE : 0.5738 (-5.83%)
Proactive news headlines including Kingwest Resources, Alice Queen, Andromeda Metals and Imugene

Sydney, July 27, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

KWR : 152.60 (+3.46%)
ADN : 2.52 (-0.40%)
SOR : 37.33 (+2.50%)
AGE : 0.5738 (-5.83%)
AgeX Therapeutics and LyGenesis Terminate Merger Negotiations

AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and cell regeneration, and LyGenesis, Inc. (“LyGenesis”), a privately held...

AGE : 0.5738 (-5.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

AgeX Therapeutics Inc. is involved in the development and commercialization of novel therapeutics targeting human aging. The company's proprietary technology consists of PureStem(R) and Tissue Regeneration(TM). Its product pipeline includes AGEX-VASC1, AGEX-BAT1, AGEX-iTR1547 and Renelon(TM). AgeX Therapeutics...

See More

Key Turning Points

3rd Resistance Point 0.6841
2nd Resistance Point 0.6621
1st Resistance Point 0.6179
Last Price 0.5738
1st Support Level 0.5517
2nd Support Level 0.5297
3rd Support Level 0.4855

See More

52-Week High 1.7100
Fibonacci 61.8% 1.2540
Fibonacci 50% 1.1131
Fibonacci 38.2% 0.9722
Last Price 0.5738
52-Week Low 0.5162

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar